Sarcopenia: rastreio, diagnóstico e manejo clínico
Palavras-chave:
Sarcopenia, Idoso, RevisãoResumo
A última década trouxe grandes avanços acerca do conceito e do melhor entendimento sobre a sarcopenia. Atualmente, a sarcopenia é reconhecida como uma doença muscular e de natureza multifatorial e sistêmica, cuja redução da força muscular é o determinante principal para disparar o gatilho de sua investigação diagnóstica. Atuais evidências enfatizam o impacto da função muscular em detrimento à perda de massa muscular, assim como ratificam o impacto terapêutico da reabilitação nutricional e física como pilares da intervenção. Apesar de muitos avanços, a sarcopenia continua negligenciada e subtratada na prática clínica regular dos pacientes idosos. Desta forma, esta revisão narrativa tem como objetivo documentar os principais instrumentos de rastreio e diagnóstico, assim como citar as evidências mais recentes no que se refere ao manejo terapêutico da sarcopenia na prática clínica.
Downloads
Referências
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. doi:10.1093/ageing/afq034
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. doi:10.1093/ageing/afq034
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis [published correction appears in Age Ageing. 2019 Jul 1;48(4):601]. Age Ageing. 2019;48(1):16-31. doi:10.1093/ageing/afy169
Thompson DD. Aging and sarcopenia. J Musculoskelet Neuronal Interact. 2007;7(4):344-345. Disponível em: https://pubmed.ncbi.nlm.nih.gov/18094505/.
Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693-700. doi:10.1097/MCO.0b013e328312c37d.
Olde Rikkert MG, Rigaud AS, van Hoeyweghen RJ, de Graaf J. Geriatric syndromes: medical misnomer or progress in geriatrics?. Neth J Med. 2003;61(3):83-87. Disponível em: https://pubmed.ncbi.nlm.nih.gov/12765229/
Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1-7. doi:10.1097/MCO.0b013e328333c1c1.
Murphy RA, Ip EH, Zhang Q, et al. Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci. 2014;69(6):751-758. doi:10.1093/gerona/glt131.
Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80-85. doi:10.1111/j.1532-5415.2004.52014.x.
Cooper R, Bann D, Wloch EG, Adams JE, Kuh D. “Skeletal muscle function deficit” in a nationally representative British birth cohort in early old age. J Gerontol A Biol Sci Med Sci 2015; 70: 604–607. DOI: 10.1093/gerona/glu214
Yoshida D, Suzuki T, Shimada H, et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int. 2014;14 Suppl 1:46-51. doi:10.1111/ggi.12210
Diz JB, Leopoldino AA, Moreira BS, et al. Prevalence of sarcopenia in older Brazilians: A systematic review and meta-analysis. Geriatr Gerontol Int. 2017;17(1):5-16. doi:10.1111/ggi.12720
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748-759. doi:10.1093/ageing/afu115
Keller K, Engelhardt M. Strength and muscle mass loss with aging process. Age and strength loss. Muscles Ligaments Tendons J. 2014;3(4):346-350. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24596700/
Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci. 2008;63(8):829-834. doi:10.1093/gerona/63.8.829
Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr. 2012;31(5):583-601. doi:10.1016/j.clnu.2012.06.010.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156. doi:10.1093/gerona/56.3.m146
Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531-532. doi:10.1016/j.jamda.2013.05.018
Barbosa-Silva TG, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC; Grupo de Estudos em Composição Corporal e Nutrição (COCONUT). Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc. 2016;17(12):1136-1141. doi:10.1016/j.jamda.2016.08.004
Peel NM, Kuys SS, Klein K. Gait speed as a measure in geriatric assessment in clinical settings: a systematic review. J Gerontol A Biol Sci Med Sci. 2013;68(1):39-46. doi:10.1093/gerona/gls174
Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142-148. doi:10.1111/j.1532-5415.1991.tb01616.x
Khow KSF, Yu SCY. An Overview of Frailty and Sarcopenia in Older People. J Aging Geriatr Med. 2017.
Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017;18(6):553.e1-553.e16. doi:10.1016/j.jamda.2017.03.019
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748-759. doi:10.1093/ageing/afu115
von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129-133. doi:10.1007/s13539-010-0014-2
Borde R, Hortobágyi T, Granacher U. Dose-Response Relationships of Resistance Training in Healthy Old Adults: A Systematic Review and Meta-Analysis. Sports Med. 2015;45(12):1693-1720. doi:10.1007/s40279-015-0385-9.
Manini TM, Clark BC, Tracy BL, Burke J, Ploutz-Snyder L. Resistance and functional training reduces knee extensor position fluctuations in functionally limited older adults. Eur J Appl Physiol. 2005;95(5-6):436-446. doi:10.1007/s00421-005-0048-x
Ramirez-Campillo R, Alvarez C, Garcìa-Hermoso A, et al. High-speed resistance training in elderly women: Effects of cluster training sets on functional performance and quality of life [published correction appears in Exp Gerontol. 2019 Jun;120:113]. Exp Gerontol. 2018;110:216-222. doi:10.1016/j.exger.2018.06.014
Lazarus NR, Izquierdo M, Higginson IJ, Harridge SDR. Exercise Deficiency Diseases of Ageing: The Primacy of Exercise and Muscle Strengthening as First-Line Therapeutic Agents to Combat Frailty. J Am Med Dir Assoc. 2018;19(9):741-743. doi:10.1016/j.jamda.2018.04.014.
Barbalho MSM, Gentil P, Izquierdo M, Fisher J, Steele J, Raiol RA. There are no no-responders to low or high resistance training volumes among older women. Exp Gerontol. 2017;99:18-26. doi:10.1016/j.exger.2017.09.003.
Law TD, Clark LA, Clark BC. Resistance Exercise to Prevent and Manage Sarcopenia and Dynapenia. Annu Rev Gerontol Geriatr. 2016;36(1):205-228. doi:10.1891/0198-8794.36.205
Deutz NE, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014;33(6):929-936. doi:10.1016/j.clnu.2014.04.007
Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. doi:10.1016/j.jamda.2013.05.021.
Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017;18(6):553.e1-553.e16. doi:10.1016/j.jamda.2017.03.019.
Fitschen PJ, Biruete A, Jeong J, Wilund KR. Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in maintenance hemodialysis patients. Hemodial Int. 2017;21(1):107-116. doi:10.1111/hdi.12440.
Gumieiro DN, Murino Rafacho BP, Buzati Pereira BL, et al. Vitamin D serum levels are associated with handgrip strength but not with muscle mass or length of hospital stay after hip fracture. Nutrition. 2015;31(7-8):931-934. doi:10.1016/j.nut.2014.12.022.
Girgis CM, Baldock PA, Downes M. Vitamin D, muscle and bone: Integrating effects in development, aging and injury. Mol Cell Endocrinol. 2015;410:3-10. doi:10.1016/j.mce.2015.03.020
Murad MH, Elamin KB, Abu Elnour NO, et al. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis [published correction appears in J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1495]. J Clin Endocrinol Metab. 2011;96(10):2997-3006. doi:10.1210/jc.2011-1193
Holick MF. Bioavailability of vitamin D and its metabolites in black and white adults. N Engl J Med. 2013;369(21):2047-2048. doi:10.1056/NEJMe1312291
McKee A, Morley JE, Matsumoto AM, Vinik A. SARCOPENIA: AN ENDOCRINE DISORDER?. Endocr Pract. 2017;23(9):1140-1149. doi:10.4158/EP171795.RA
Huff H, Merchant AT, Lonn E, Pullenayegum E, Smaill F, Smieja M. Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians. HIV Med. 2018;19(2):143-151. doi:10.1111/hiv.12563.
Cornish SM, Chilibeck PD. Alpha-linolenic acid supplementation and resistance training in older adults. Appl Physiol Nutr Metab. 2009;34(1):49-59. doi:10.1139/H08-136
Papanicolaou DA, Ather SN, Zhu H, et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J Nutr Health Aging. 2013;17(6):533-543. doi:10.1007/s12603-013-0335-x
Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005;63(3):280-293. doi:10.1111/j.1365-2265.2005.02339.x
Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018;22(10):1148-1161. doi:10.1007/s12603-018-1139-9
